Pro-invasive role of MMP-9 and c-Met in faslodex-resistant breast cancer
The pure anti-oestrogen faslodex presents a valuable therapeutic option for post-menopausal women with endocrine-sensitive advanced breast cancer. However, emergence of resistance following long-term treatment constitutes a major clinical problem as faslodex-refractory disease is associated with poo...
Main Author: | |
---|---|
Published: |
Cardiff University
2009
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.584747 |